@FierceMedDev: Sundance sees future for companion Dx to measure drug-related suicide risk. Story | Follow @FierceMedDev
@MarkHFierce: Huge: Navidea's lymph node Dx mapping agent is the first of its kind to gain the FDA's blessing in 30 years. Article | Follow @MarkHFierce
@DamianFierce: Add "find a new CFO" to Quest Diagnostics' "stop shrinking" checklist. Release | Follow @DamianFierce
> Sluggish 2012 sales for Johnson & Johnson ($JNJ) mean the company's execs didn't get their full bonuses, and CEO Alex Gorsky made just over one-third of what former chief William Weldon hauled in. Article
> Patients implanted with St. Jude Medical's ($STJ) now-recalled Riata leads face a tough decision on risky revision surgeries. Story
> Covidien ($COV) is launching three new, FDA-cleared hernia care products, used in laparoscopic inguinal, ventral and umbilical hernia repair. Release
> Orthofix ($OFIX) has appointed Brad Mason to be its CEO, replacing Robert Vaters, who steered the company through a kickback scandal finally resolved in December. More
> Volcano ($VOLC) has launched its Valet Microcatheter in the U.S. and Europe, touting the device as ideal in complex coronary and peripheral interventional procedures for highly stenosed lesions. Item
> The body produces quite a bit of unused energy in the course of basic function, and researchers are working to harness the surplus to power medical devices. News
> Diagnostics outfit Transgenomic reported a 15% drop in revenue in the fourth quarter, leading to a net loss of $2.3 million. Full results
Biotech News
@FierceBiotech: From FierceBiomarkers.com: GenoMine test spots three new kidney cancer biomarkers. Story | Follow @FierceBiotech
@JohnCFierce: FDA proposes to dramatically lower the bar on Alzheimer's drugs. Story | Follow @JohnCFierce
@RyanMFierce: Mesoblast, developer of stem cell therapy for degenerative spine, landed A$170M. Good for regenerative rx field: Release | Follow @RyanMFierce
> Researchers, biopharma companies protest budget cuts at FDA, NIH. More
> Cytos Biotechnology soars on results of asthma-drug study. Item
> Presidio rebounds with Boehringer hep C cocktail collaboration. News
Pharma News
@FiercePharma: Free generic Lipitor! Wegmans' pharmacy uses atorvastatin as a loss-leader. Cash price? $67.88. Story | Follow @FiercePharma
@EricPFierce: Hikma has started up production at NJ plant that got FDA warning letter, while injectables going gangbusters. Article | Follow @EricPFierce
> Pfizer takes Indian patent fight to Capitol Hill. News
> Novartis rolls out iPhone apps for cancer patients. More
> Ex-J&J chief's 2012 pay outclasses Gorsky's by almost 3-to-1. Article
Pharma Manufacturing News
> Drugmakers press Congress on sequestered fees slated for inspections. Story
> Moves to help ease drug shortages undercut Spectrum. Item
> Mitsubishi pushes into India with Neuland API deal. Article
> EU API law has drugmakers there in panic. Report
> Hikma's injectables biz rides competitors' woes to new heights. More
Vaccines News
> Top 5 Vaccine Companies by Revenue - 2012. Special Report
> Experts weigh in on smallpox preparedness. Article
> Vaccines falter in fight against whooping cough. News
> Narcolepsy link raises doubts about next-gen adjuvants. Story
> Experts weigh in on smallpox preparedness. More